Europe is exploring drug pricing proposals with the Trump administration amid pressure over drug costs and tariffs.
2 reports, 1 independent
Updated Sep 21
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Europe is exploring drug pricing proposals with the Trump administration amid pressure over drug costs and tariffs.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- The administration announced new tariffs on foreign drug manufacturers, impacting the global pharmaceutical industry.Sub-event
Europe is discussing drug pricing proposals with the Trump administration.1 source
Keep exploring
The entities involved
-
Europe
terrestrial continent located in north-western Eurasia
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
Related events
- Roberta Metsola advised Germany to seek a deal with the Trump administration amid an ongoing drug pricing trade dispute.
- The Trump administration is currently negotiating tariffs.
- Trump's tariff deadline is reportedly pressuring European stock markets.
- Trump's tariff plan caused markets to tank, impacting Donnelley Financial Solutions.
- The Institute for Supply Management noted on August 8, 2025, that tariffs from the Trump administration were causing market volatility and hurting industry and consumers.